Psoriasis Therapeutics and Marketing
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be …
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be … 
Have you received your August issue of the JDD yet? This month's issue contains a special focus on Psoriasis, as August is Psoriasis Awareness Month! Below are the issue highlights and Editor Picks for the August issue of JDD!
In Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years, high levels of effi … 
While previously thought to be a rare diagnosis in non-white racial ethnic groups, more recent data has shown that psoriasis in patients with skin of color is much more common than was once thought. Dr. Andrew Alexis spoke during the Skin of Color Seminar Series (now Skin of Color Update) in New York City on May 5th, 2018 on this condition and on the important differences in clinical characteristi … 
PART 2
The well-known Dr. Gil Yosipovitch, Professor of Dermatology at the University of Miami Miller School of Medicine and Director of the Miami Itch Center, recently lectured on various aspects of itch at the 2018 ODAC meeting. He has asked his two research fellows to write on the topic for Next Steps in Dermatology. This is the second article in our 2-part series.
Counseling patien … 
PART 1
The well-known Dr. Gil Yosipovitch, Professor of Dermatology at the University of Miami Miller School of Medicine and Director of the Miami Itch Center, recently lectured on various aspects of itch at the 2018 ODAC meeting. He has asked his two research fellows to write on the topic for Next Steps in Dermatology. This is the first article in a 2-part series about itch.
A …